MDS Latest News
Following the publication of emerging evidence that the Pfizer COVID vaccines are less effective for cancer patients after a single dose, the Blood Cancer Alliance (BCA) has today written to […]
Read full story
Shielding guidance for those who are clinically extremely vulnerable from COVID-19 – from the Department of Health and Social Care. See below for the latest advice to patients by the […]
Read full story
Patients with blood cancers such as leukaemia vary in their immune response to COVID-19 and can struggle to clear infection for very many weeks, according to new research published in Cancer […]
Read full story
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? TP53 gene mutations or chromosome 17 loss which results in TP53 deletion is […]
Read full story
Dear MDS UK members, We hope you have been coping as best as possible during this very difficult year for everyone. From the many phone calls and emails we have […]
Read full story
Christmas Poem 2020 – by Kate D. A tradition of traditions that once a year consumes us with Nutcracker images, ginger and spice, stockings and F.C., a decorated tree. But […]
Read full story
Welcome to our “#20for20 Charity Shop”. This is the place where our amazing fundraisers are swapping things for donations! What an excellent way to support MDS UK! How does it […]
Read full story
- SUB-TYPE OF MDS: Low risk MDS patients
- SEVERITY OF MDS: IPSS Low or Intermediate-1 risk MDS
- NAME OF DRUG: Imetelstat
Christmas is just around the corner and it will look drastically different for millions of people across the globe this year. Hope and encouragement will be needed to find safe […]
Read full story
Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? The innovative drug Imetelstat has been trialed on patients with lower-risk MDS who […]
Read full story